MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'charles grassley'. Sat, 03 Sep 2011 02:40:45 +0100 http://www.medworm.com/index.php?rid=4424216&cid=t_194524_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2Fvkx4wny6XWE%2F By Tad DeHavenThat’s what the Department of Housing and Urban Development’s recently retired inspector general had to say in response to rampant malfeasance and mismanagement at public housing authorities uncovered by a joint investigation by ABC News and The Center for Public Integrity. From the report: The problems are widespread, from an executive in New Orleans convicted of embezzling more than $900,000 in housing money around the time he bought a lavish Florida mansion to federal funds wrongly being spent to provide housing for sex offenders or to pay vouchers to residents long since dead. Despite red flags from its own internal watchdog, HUD has continued to plow fresh federal dollars into these troubled agencies, including $218 million in stimulus funds since 2009, the joint inv... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=4424216 Tue, 01 Feb 2011 14:02:30 +0100 4424216 http://www.medworm.com/index.php?rid=4343331&cid=t_194524_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FMzN0NGIvnh4%2F In 2008, the US Senate Finance Committee charged that Stanford University failed to properly monitor alleged conflicts of interest involving Alan Schatzberg, the former chair of its psychiatry department, who owned a substantive amount of stock in Corcept Therapeutics, which was studying the development of mifepristone, or RU-486, for treating psychiatric depression. Beyond his stock holdings, Schatzberg was also listed as a co-patent holder for the drug, which is best known for inducing abortion, and he received a grant from the National Institutes of Health to oversee the research. The allegation was part of a lengthy probe into the wider issue of taxpayer-funded research and undisclosed and unmonitored conflicts involving universities, academic researchers and the pharmaceutical industr... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4343331 Thu, 13 Jan 2011 14:26:00 +0100 4343331 http://www.medworm.com/index.php?rid=3805777&cid=t_194524_83_f&fid=34856&url=http%3A%2F%2Finsidesurgery.com%2F2010%2F07%2Fsenator-charles-grassley-investigating-maker-artificial-hips-knees%2F Iowa senatory Charles E. Grassley has contacted Zimmer Holdings of Warsaw, Indiana regarding their policy for handling complaints about the performance and safety of their artificial knees and hips. (Source: Inside Surgery) Inside Surgery blogs http://www.medworm.com/rss/comments.php?id=3805777 Fri, 30 Jul 2010 23:53:23 +0100 3805777 http://www.medworm.com/index.php?rid=3641321&cid=t_194524_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FrYivhU7sae4%2F The Charles Nemeroff affair encompasses more people all the time. Now, the University of Miami Medical School has become ensnared in the ongoing probe launched by US Senator Chuck Grassley, who investigated Nemeroff as part of an inquiry into undisclosed financial conflicts of intereest among academic researchers who receive federal grants. You may recall Nemeroff, who was recently hired by the University of Miami, had departed Emory University after the Senate probe disclosed he was accepting sizeable consulting fees from GlaxoSmithKline at the same time he was the primary investigator on an NIH-funded grant for research into a Glaxo drug (see this). Before his departure, Emory imposed a two-year ban on grants for on Nemeroff. This week, however, the U of Miami med school head, Pascal Gol... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3641321 Tue, 08 Jun 2010 15:44:41 +0100 3641321 http://www.medworm.com/index.php?rid=3359212&cid=t_194524_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F1uEtOjqcfck%2F In his latest attempt to probe the pharmaceutical industry, US Senator Chuck Grassley has written two big pharmacy benefit managers, as well as a trade group, asking them to provide information about their financial relationships with drugmakers. This week, he sent letters to Express Scripts, CVS Caremark and the Pharmaceutical Care Management Association (click on name to see letters). In explaining his action, Grassley - who is the ranking Republican on the Senate Finance Committee - wrote that the Medicare Payment Advisory Commission (MedPAC) recommended in a report last year that Congress should require drugmakers to report their financial relationships with pharmacy benefit managers, pharmacies, health plans, and others, but not rebates or discounts (look here). And so he asks for det... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3359212 Fri, 12 Mar 2010 15:05:05 +0100 3359212 http://www.medworm.com/index.php?rid=3106769&cid=t_194524_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F12%2F20%2Fmental-health-year-in-review-2009%2F Another year is over, and so brings us to the close of another year of great stories, great friends, and great insights into the world of psychology — our annual Year in Review of Mental Health. Conflicts of Interest, Lawsuits and Transparency Perhaps 2009 will be noted as the year of reckoning for pharmaceutical companies, who have not enjoyed good press this year. In January, we noted how Eli Lilly settled a Zyprexa lawsuit for $1.4 billion with 30 states due to its off-label marketing of the atypical antipsychotic drug for use in dementia and Alzheimer’s disease. Philip over at Furious Seasons puts the total Zyprexa tab at $2.8 billion with settlements with 39 states, with another 6 states pending. Keeping in mind that Zyprexa has had $37 billion in sales since its introduc... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=3106769 Sun, 20 Dec 2009 10:55:38 +0100 3106769 http://www.medworm.com/index.php?rid=2313540&cid=t_194524_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F04%2F07%2Fnext-up-nonprofits-and-pharmaceutical-funding%2F Well, if you’ve been involved in the mental health field for any amount of time, you knew it was only a matter of time. U.S. Senator Charles Grassley first focused on the low-hanging fruit — researchers with unreported conflicts of interest (usually unreported money) from pharmaceutical companies, the same companies they conducted drug research for. Now he’s examining nonprofits in mental health, and first up is the National Alliance for Mental Illness (NAMI). Senator Grassley has made clear that this isn’t a witch-hunt as much as a desire to get to the bottom of how the pharmaceutical industry funds its practices that makes it products so popular and widespread. It’s not about receiving money from pharmaceutical companies per se’, but rather being upfro... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=2313540 Tue, 07 Apr 2009 11:22:04 +0100 2313540 http://www.medworm.com/index.php?rid=1655670&cid=t_194524_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F345833615%2F The ranking Republican on the Senate Finance Committee wants the National Institutes of Health to revoke grants to academic scientists who fail to report financial conflicts of interest to their institutions, the Iowa Senator tells The Chronicle of Higher Education. His remarks come after targeting Harvard University, Stanford University and the University of Cincinnati, because some academics underreported their own financial interests in research projects supported by the NIH. Institutions are required by federal regulation to report the existence of those conflicts to the agency. Grassley is seeking info from 20 other institutions about financial conflicts among their scientists, including Brown University’s Martin Keller, and the American Psychiatric Association. Since 1995, an N... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1655670 Fri, 25 Jul 2008 17:01:05 +0100 1655670